Target intelligence / Profile preview

Systemic immune and neural microenvironment

Molecular classification
Other
01

Overview

The systemic immune and neural microenvironment represents the integrated network of signaling between the central and peripheral nervous systems and the immune system. This bidirectional communication is mediated by a variety of molecular messengers, including cytokines, neurotransmitters, and neuropeptides, which allow the brain to monitor and modulate immune activity while the immune system influences neural function (Ref: PMID: 28802038). Dysregulation of this microenvironment is a hallmark of several conditions, including chronic inflammatory diseases, neurodegeneration, and the progression of the tumor microenvironment, where neural signaling can promote or suppress anti-tumor immunity (Ref: PMID: 31534244). Because it is a systemic physiological state rather than a single protein or receptor, it is not considered a discrete therapeutic target; however, many individual components within this environment, such as cytokine receptors or adrenergic receptors, serve as specific targets for drug intervention (Ref: PMID: 32054582). Therapeutic strategies often aim to restore the balance of this axis to treat complex pathologies that span both the neurological and immunological domains.

Other names
Neuro-immune axisNeuroimmune microenvironmentSystemic neuro-immune interactionNeuro-immune interface
02

Mechanism of action

Modulation of bidirectional signaling between the nervous and immune systems via neurotransmitters, cytokines, and cell-trafficking inhibitors.

03

Biological functions

Immune responseSignal transductionHomeostasisNeurotransmissionInflammation
04

Disease associations

Neurodegenerative diseaseCancerAutoimmune diseaseChronic painInflammation
05

Safety considerations

Systemic immunosuppressionNeurological side effectsOff-target organ toxicityComplexity of multi-organ feedback loops
06

Interacting drugs

Fingolimod

3 more in the full profile.

07

Biomarkers

Circulating cytokines (e.g., IL-6, TNF-alpha)Neurotransmitter levels (e.g., Acetylcholine, Norepinephrine)Immune cell phenotypes (e.g., T-cell activation markers)C-reactive protein (CRP)

Beyond the preview

Go deeper on Systemic immune and neural microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic immune and neural microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call